

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of sequestering of triglyceride (GO:0010889) | 6.68519718 |
| 2 | * low-density lipoprotein particle clearance (GO:0034383) | 5.47556497 |
| 3 | * regulation of cholesterol storage (GO:0010885) | 4.80061786 |
| 4 | cellular response to epinephrine stimulus (GO:0071872) | 4.62488503 |
| 5 | triglyceride catabolic process (GO:0019433) | 4.57312942 |
| 6 | valine metabolic process (GO:0006573) | 4.49280625 |
| 7 | carnitine shuttle (GO:0006853) | 4.37428054 |
| 8 | brown fat cell differentiation (GO:0050873) | 4.35383565 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.30887795 |
| 10 | fatty acid beta-oxidation (GO:0006635) | 4.11427628 |
| 11 | response to epinephrine (GO:0071871) | 4.09661820 |
| 12 | acylglycerol catabolic process (GO:0046464) | 4.09444027 |
| 13 | neutral lipid catabolic process (GO:0046461) | 4.09444027 |
| 14 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 4.06562506 |
| 15 | * fatty acid transmembrane transport (GO:1902001) | 3.99148129 |
| 16 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.90860983 |
| 17 | positive regulation of fatty acid oxidation (GO:0046321) | 3.83786098 |
| 18 | biotin metabolic process (GO:0006768) | 3.73891796 |
| 19 | negative regulation of lipid storage (GO:0010888) | 3.71712183 |
| 20 | diacylglycerol metabolic process (GO:0046339) | 3.70875077 |
| 21 | white fat cell differentiation (GO:0050872) | 3.69748119 |
| 22 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.68892554 |
| 23 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.67449526 |
| 24 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.62786447 |
| 25 | fatty acid oxidation (GO:0019395) | 3.61541956 |
| 26 | carnitine transmembrane transport (GO:1902603) | 3.59285694 |
| 27 | lipid oxidation (GO:0034440) | 3.58990510 |
| 28 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.55372142 |
| 29 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.52469355 |
| 30 | * positive regulation of lipid storage (GO:0010884) | 3.49254874 |
| 31 | intracellular lipid transport (GO:0032365) | 3.46627202 |
| 32 | fatty acid catabolic process (GO:0009062) | 3.44377899 |
| 33 | amino-acid betaine transport (GO:0015838) | 3.40387934 |
| 34 | carnitine transport (GO:0015879) | 3.40387934 |
| 35 | regulation of fatty acid oxidation (GO:0046320) | 3.39145890 |
| 36 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.38474795 |
| 37 | surfactant homeostasis (GO:0043129) | 3.34838782 |
| 38 | ovulation from ovarian follicle (GO:0001542) | 3.34816991 |
| 39 | barbed-end actin filament capping (GO:0051016) | 3.32808995 |
| 40 | * lipid storage (GO:0019915) | 3.31988457 |
| 41 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.31439349 |
| 42 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.31439349 |
| 43 | modulation by symbiont of host immune response (GO:0052553) | 3.31439349 |
| 44 | positive regulation by symbiont of host defense response (GO:0052509) | 3.31439349 |
| 45 | modulation by symbiont of host defense response (GO:0052031) | 3.31439349 |
| 46 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.31439349 |
| 47 | growth hormone receptor signaling pathway (GO:0060396) | 3.21738767 |
| 48 | neutrophil activation involved in immune response (GO:0002283) | 3.21271559 |
| 49 | tricarboxylic acid cycle (GO:0006099) | 3.20607609 |
| 50 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.20383600 |
| 51 | response to dietary excess (GO:0002021) | 3.18817704 |
| 52 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.18327711 |
| 53 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.18327711 |
| 54 | polyol transport (GO:0015791) | 3.17366470 |
| 55 | alpha-linolenic acid metabolic process (GO:0036109) | 3.13586751 |
| 56 | negative regulation of macrophage differentiation (GO:0045650) | 3.13388066 |
| 57 | branched-chain amino acid metabolic process (GO:0009081) | 3.11019710 |
| 58 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.10110732 |
| 59 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.09437100 |
| 60 | lipid particle organization (GO:0034389) | 3.08774529 |
| 61 | * regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.06909604 |
| 62 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.06757282 |
| 63 | * regulation of lipid storage (GO:0010883) | 3.06651815 |
| 64 | triglyceride biosynthetic process (GO:0019432) | 3.05040861 |
| 65 | keratan sulfate catabolic process (GO:0042340) | 3.04552673 |
| 66 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.04015513 |
| 67 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.03414140 |
| 68 | transcytosis (GO:0045056) | 3.03192949 |
| 69 | oxaloacetate metabolic process (GO:0006107) | 3.03168205 |
| 70 | positive regulation of lipid catabolic process (GO:0050996) | 3.02253618 |
| 71 | ethanol oxidation (GO:0006069) | 3.01658989 |
| 72 | membrane raft organization (GO:0031579) | 3.01503261 |
| 73 | tricarboxylic acid metabolic process (GO:0072350) | 3.01183735 |
| 74 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.00797542 |
| 75 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.00251806 |
| 76 | negative regulation of phagocytosis (GO:0050765) | 2.96269337 |
| 77 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.96083039 |
| 78 | branched-chain amino acid catabolic process (GO:0009083) | 2.95873419 |
| 79 | phosphatidic acid biosynthetic process (GO:0006654) | 2.95625303 |
| 80 | phosphatidic acid metabolic process (GO:0046473) | 2.95625303 |
| 81 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.93621358 |
| 82 | neutral lipid biosynthetic process (GO:0046460) | 2.92906893 |
| 83 | acylglycerol biosynthetic process (GO:0046463) | 2.92906893 |
| 84 | glomerular filtration (GO:0003094) | 2.90687493 |
| 85 | acetyl-CoA metabolic process (GO:0006084) | 2.89605670 |
| 86 | * plasma lipoprotein particle clearance (GO:0034381) | 2.87823613 |
| 87 | positive regulation of glomerulus development (GO:0090193) | 2.87585087 |
| 88 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.85177319 |
| 89 | glycerolipid catabolic process (GO:0046503) | 2.84893487 |
| 90 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.82742257 |
| 91 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.82724002 |
| 92 | 2-oxoglutarate metabolic process (GO:0006103) | 2.82645414 |
| 93 | positive regulation of p38MAPK cascade (GO:1900745) | 2.82460170 |
| 94 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.81819195 |
| 95 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.81077600 |
| 96 | potassium ion export (GO:0071435) | 2.80155668 |
| 97 | regulation of lipoprotein metabolic process (GO:0050746) | 2.80036499 |
| 98 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.79528793 |
| 99 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.79103600 |
| 100 | regulation of cholesterol efflux (GO:0010874) | 2.78374192 |
| 101 | positive regulation of interferon-alpha production (GO:0032727) | 2.77535299 |
| 102 | detection of molecule of bacterial origin (GO:0032490) | 2.76954067 |
| 103 | acyl-CoA biosynthetic process (GO:0071616) | 2.76026997 |
| 104 | thioester biosynthetic process (GO:0035384) | 2.76026997 |
| 105 | cellular response to growth hormone stimulus (GO:0071378) | 2.75133895 |
| 106 | * response to hydroperoxide (GO:0033194) | 2.74497554 |
| 107 | monocarboxylic acid catabolic process (GO:0072329) | 2.74469048 |
| 108 | iron ion import (GO:0097286) | 2.74108899 |
| 109 | regulation of triglyceride catabolic process (GO:0010896) | 2.73156382 |
| 110 | triglyceride metabolic process (GO:0006641) | 2.72861822 |
| 111 | complement activation, alternative pathway (GO:0006957) | 2.72395670 |
| 112 | negative regulation of protein autophosphorylation (GO:0031953) | 2.71932387 |
| 113 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.69235607 |
| 114 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.66256259 |
| 115 | carnitine metabolic process (GO:0009437) | 2.64741387 |
| 116 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.64101118 |
| 117 | fatty acid homeostasis (GO:0055089) | 2.64033528 |
| 118 | response to vitamin E (GO:0033197) | 2.61312414 |
| 119 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.59881384 |
| 120 | quaternary ammonium group transport (GO:0015697) | 2.59731160 |
| 121 | negative regulation of granulocyte differentiation (GO:0030853) | 2.59717172 |
| 122 | regulation of interferon-alpha production (GO:0032647) | 2.59210914 |
| 123 | positive regulation of cholesterol efflux (GO:0010875) | 2.57343657 |
| 124 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.56705323 |
| 125 | regulation of cholesterol transport (GO:0032374) | 2.56409612 |
| 126 | regulation of sterol transport (GO:0032371) | 2.56409612 |
| 127 | regulation of platelet activation (GO:0010543) | 2.56147209 |
| 128 | acylglycerol metabolic process (GO:0006639) | 2.55932288 |
| 129 | * positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.55524817 |
| 130 | chemical homeostasis within a tissue (GO:0048875) | 2.55231099 |
| 131 | renal filtration (GO:0097205) | 2.55135841 |
| 132 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.54609604 |
| 133 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.54064146 |
| 134 | positive regulation of cholesterol transport (GO:0032376) | 2.53857096 |
| 135 | positive regulation of sterol transport (GO:0032373) | 2.53857096 |
| 136 | glycerol metabolic process (GO:0006071) | 2.53145919 |
| 137 | detection of other organism (GO:0098543) | 2.52742833 |
| 138 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.51623265 |
| 139 | angiogenesis involved in wound healing (GO:0060055) | 2.51018817 |
| 140 | neutral lipid metabolic process (GO:0006638) | 2.50876895 |
| 141 | cellular response to zinc ion (GO:0071294) | 2.50405142 |
| 142 | regulation of macrophage chemotaxis (GO:0010758) | 2.49266467 |
| 143 | positive regulation of receptor recycling (GO:0001921) | 2.49229584 |
| 144 | phospholipid homeostasis (GO:0055091) | 2.48929991 |
| 145 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.47825124 |
| 146 | NADH metabolic process (GO:0006734) | 2.47621175 |
| 147 | positive regulation of mast cell activation (GO:0033005) | 2.47539213 |
| 148 | response to thyroid hormone (GO:0097066) | 2.47433840 |
| 149 | wound healing, spreading of epidermal cells (GO:0035313) | 2.46922660 |
| 150 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.45664224 |
| 151 | succinate metabolic process (GO:0006105) | 2.45232712 |
| 152 | response to lipoprotein particle (GO:0055094) | 2.44629880 |
| 153 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.44225663 |
| 154 | regulation of mononuclear cell migration (GO:0071675) | 2.43283561 |
| 155 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.42753510 |
| 156 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.42414948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.83989014 |
| 2 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.23856847 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.98318466 |
| 4 | * GATA1_22025678_ChIP-Seq_K562_Human | 3.56142625 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.50818162 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.33065156 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.21765888 |
| 8 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.21605446 |
| 9 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.86569750 |
| 10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.80978679 |
| 11 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.67632281 |
| 12 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.48418474 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.43093134 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.42926752 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.35969800 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.27369950 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.20469546 |
| 18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.19153876 |
| 19 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.14724159 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.14366704 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.13378054 |
| 22 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.10915201 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.08093023 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.02183530 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.96553097 |
| 26 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80523767 |
| 27 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.79509824 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.77108005 |
| 29 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.76875774 |
| 30 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.72353108 |
| 31 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.71420089 |
| 32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.70709710 |
| 33 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.69074402 |
| 34 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.63845333 |
| 35 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.62369214 |
| 36 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.62369214 |
| 37 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.60237283 |
| 38 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.59937487 |
| 39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.58609749 |
| 40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54914646 |
| 41 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.54319149 |
| 42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.50022110 |
| 43 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.48813191 |
| 44 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.48117635 |
| 45 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.47328242 |
| 46 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45297343 |
| 47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.44654373 |
| 48 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.43537344 |
| 49 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40870976 |
| 50 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.40701371 |
| 51 | CJUN_26792858_Chip-Seq_BT549_Human | 1.39070035 |
| 52 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.38635762 |
| 53 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.38635762 |
| 54 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.38539449 |
| 55 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.37958502 |
| 56 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31598767 |
| 57 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.30158208 |
| 58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.29504047 |
| 59 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.27124242 |
| 60 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.26844312 |
| 61 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.26038385 |
| 62 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.24039685 |
| 63 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19705872 |
| 64 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.18992801 |
| 65 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18909788 |
| 66 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.16684281 |
| 67 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16437671 |
| 68 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.16413319 |
| 69 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.15471736 |
| 70 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.14918046 |
| 71 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.14871541 |
| 72 | SPI1_23127762_ChIP-Seq_K562_Human | 1.14659406 |
| 73 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.14518200 |
| 74 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.11069071 |
| 75 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.10767397 |
| 76 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.08796245 |
| 77 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08460647 |
| 78 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08389261 |
| 79 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06181962 |
| 80 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.05180844 |
| 81 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.04992899 |
| 82 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.04041715 |
| 83 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.02994816 |
| 84 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.00280045 |
| 85 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.99204174 |
| 86 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.97856100 |
| 87 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97210283 |
| 88 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96239711 |
| 89 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.95575006 |
| 90 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94556588 |
| 91 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94354723 |
| 92 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94326876 |
| 93 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.94277431 |
| 94 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93591966 |
| 95 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93468244 |
| 96 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92613481 |
| 97 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92098840 |
| 98 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.91866851 |
| 99 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.90895547 |
| 100 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.90870741 |
| 101 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90564832 |
| 102 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.88567396 |
| 103 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.88255723 |
| 104 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.88021154 |
| 105 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.87436076 |
| 106 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.87187642 |
| 107 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.86575841 |
| 108 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.85449765 |
| 109 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.84973195 |
| 110 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.84198583 |
| 111 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.84198583 |
| 112 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.84046722 |
| 113 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.83688147 |
| 114 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.83373479 |
| 115 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83201637 |
| 116 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.83047029 |
| 117 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.81575443 |
| 118 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81259307 |
| 119 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80956759 |
| 120 | RXR_22108803_ChIP-Seq_LS180_Human | 0.80305933 |
| 121 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.77873169 |
| 122 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.77799808 |
| 123 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.77605270 |
| 124 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.76394983 |
| 125 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.76209543 |
| 126 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.76193663 |
| 127 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.74956356 |
| 128 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.72870255 |
| 129 | MAF_26560356_Chip-Seq_TH1_Human | 0.72719324 |
| 130 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.71566505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 4.61587633 |
| 2 | * MP0004130_abnormal_muscle_cell | 3.55442705 |
| 3 | MP0003191_abnormal_cellular_cholesterol | 3.29128612 |
| 4 | MP0005666_abnormal_adipose_tissue | 3.27603774 |
| 5 | MP0004185_abnormal_adipocyte_glucose | 3.00534703 |
| 6 | MP0003724_increased_susceptibility_to | 2.81476527 |
| 7 | MP0008438_abnormal_cutaneous_collagen | 2.61992753 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 2.52972284 |
| 9 | MP0005375_adipose_tissue_phenotype | 2.38876096 |
| 10 | MP0003828_pulmonary_edema | 2.34942533 |
| 11 | MP0003705_abnormal_hypodermis_morpholog | 2.11539902 |
| 12 | MP0002971_abnormal_brown_adipose | 2.09812862 |
| 13 | MP0005058_abnormal_lysosome_morphology | 2.07812736 |
| 14 | MP0003303_peritoneal_inflammation | 2.04106398 |
| 15 | MP0001879_abnormal_lymphatic_vessel | 1.88332234 |
| 16 | MP0005360_urolithiasis | 1.87224002 |
| 17 | * MP0010329_abnormal_lipoprotein_level | 1.86781871 |
| 18 | MP0005167_abnormal_blood-brain_barrier | 1.85762888 |
| 19 | MP0010368_abnormal_lymphatic_system | 1.79040290 |
| 20 | MP0009115_abnormal_fat_cell | 1.78517463 |
| 21 | MP0000013_abnormal_adipose_tissue | 1.75188954 |
| 22 | MP0004084_abnormal_cardiac_muscle | 1.74384328 |
| 23 | MP0001835_abnormal_antigen_presentation | 1.72572558 |
| 24 | MP0003646_muscle_fatigue | 1.71562906 |
| 25 | * MP0000343_altered_response_to | 1.68076374 |
| 26 | MP0000003_abnormal_adipose_tissue | 1.62322042 |
| 27 | MP0004272_abnormal_basement_membrane | 1.61385265 |
| 28 | MP0003436_decreased_susceptibility_to | 1.60520156 |
| 29 | MP0003656_abnormal_erythrocyte_physiolo | 1.60044535 |
| 30 | MP0004215_abnormal_myocardial_fiber | 1.59314123 |
| 31 | MP0003950_abnormal_plasma_membrane | 1.57871924 |
| 32 | MP0002332_abnormal_exercise_endurance | 1.57015531 |
| 33 | MP0008775_abnormal_heart_ventricle | 1.55765382 |
| 34 | MP0005275_abnormal_skin_tensile | 1.55470072 |
| 35 | MP0004782_abnormal_surfactant_physiolog | 1.54823068 |
| 36 | MP0005334_abnormal_fat_pad | 1.53506097 |
| 37 | * MP0002118_abnormal_lipid_homeostasis | 1.47864047 |
| 38 | MP0006036_abnormal_mitochondrial_physio | 1.47298669 |
| 39 | MP0003566_abnormal_cell_adhesion | 1.46722383 |
| 40 | MP0006138_congestive_heart_failure | 1.41608565 |
| 41 | MP0003186_abnormal_redox_activity | 1.39669820 |
| 42 | MP0001958_emphysema | 1.36896973 |
| 43 | * MP0005385_cardiovascular_system_phenoty | 1.36887927 |
| 44 | * MP0001544_abnormal_cardiovascular_syste | 1.36887927 |
| 45 | MP0005330_cardiomyopathy | 1.35945160 |
| 46 | MP0002972_abnormal_cardiac_muscle | 1.34396730 |
| 47 | MP0002139_abnormal_hepatobiliary_system | 1.34145214 |
| 48 | MP0005464_abnormal_platelet_physiology | 1.33764459 |
| 49 | MP0000751_myopathy | 1.32785383 |
| 50 | MP0004036_abnormal_muscle_relaxation | 1.31528671 |
| 51 | MP0003011_delayed_dark_adaptation | 1.27203204 |
| 52 | MP0004087_abnormal_muscle_fiber | 1.26930405 |
| 53 | MP0003300_gastrointestinal_ulcer | 1.26762782 |
| 54 | MP0000750_abnormal_muscle_regeneration | 1.25884133 |
| 55 | MP0000747_muscle_weakness | 1.25535674 |
| 56 | * MP0003690_abnormal_glial_cell | 1.25253715 |
| 57 | * MP0002419_abnormal_innate_immunity | 1.24368483 |
| 58 | MP0001533_abnormal_skeleton_physiology | 1.23879735 |
| 59 | MP0004510_myositis | 1.22762233 |
| 60 | MP0000609_abnormal_liver_physiology | 1.21521075 |
| 61 | MP0005397_hematopoietic_system_phenotyp | 1.21157525 |
| 62 | MP0001545_abnormal_hematopoietic_system | 1.21157525 |
| 63 | MP0001881_abnormal_mammary_gland | 1.20648038 |
| 64 | MP0009840_abnormal_foam_cell | 1.20223458 |
| 65 | MP0005535_abnormal_body_temperature | 1.17461697 |
| 66 | MP0001853_heart_inflammation | 1.17213047 |
| 67 | MP0001661_extended_life_span | 1.15230378 |
| 68 | MP0005620_abnormal_muscle_contractility | 1.14205533 |
| 69 | MP0005448_abnormal_energy_balance | 1.13818804 |
| 70 | MP0003279_aneurysm | 1.12384084 |
| 71 | MP0003075_altered_response_to | 1.10194982 |
| 72 | MP0000759_abnormal_skeletal_muscle | 1.09539767 |
| 73 | MP0006082_CNS_inflammation | 1.09334552 |
| 74 | MP0003448_altered_tumor_morphology | 1.09215210 |
| 75 | MP0005164_abnormal_response_to | 1.08598691 |
| 76 | MP0002970_abnormal_white_adipose | 1.08569459 |
| 77 | * MP0009785_altered_susceptibility_to | 1.08465600 |
| 78 | MP0000858_altered_metastatic_potential | 1.07935391 |
| 79 | MP0004147_increased_porphyrin_level | 1.07022515 |
| 80 | MP0010630_abnormal_cardiac_muscle | 1.05641180 |
| 81 | MP0005319_abnormal_enzyme/_coenzyme | 1.04009197 |
| 82 | MP0002876_abnormal_thyroid_physiology | 1.03172453 |
| 83 | MP0002877_abnormal_melanocyte_morpholog | 1.03158909 |
| 84 | MP0002166_altered_tumor_susceptibility | 1.03146496 |
| 85 | MP0009764_decreased_sensitivity_to | 1.02422687 |
| 86 | MP0005365_abnormal_bile_salt | 1.02413426 |
| 87 | MP0000249_abnormal_blood_vessel | 1.02088659 |
| 88 | MP0008004_abnormal_stomach_pH | 1.01961344 |
| 89 | MP0002148_abnormal_hypersensitivity_rea | 1.01610204 |
| 90 | MP0002254_reproductive_system_inflammat | 1.01286143 |
| 91 | * MP0005025_abnormal_response_to | 1.00172656 |
| 92 | MP0003045_fibrosis | 0.97848716 |
| 93 | MP0002138_abnormal_hepatobiliary_system | 0.97481539 |
| 94 | MP0009643_abnormal_urine_homeostasis | 0.96050848 |
| 95 | MP0002638_abnormal_pupillary_reflex | 0.95603317 |
| 96 | MP0001986_abnormal_taste_sensitivity | 0.94753400 |
| 97 | MP0000749_muscle_degeneration | 0.94253429 |
| 98 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.93337993 |
| 99 | MP0005452_abnormal_adipose_tissue | 0.92980014 |
| 100 | MP0002998_abnormal_bone_remodeling | 0.92567648 |
| 101 | * MP0002078_abnormal_glucose_homeostasis | 0.91690056 |
| 102 | MP0004484_altered_response_of | 0.91493986 |
| 103 | MP0005000_abnormal_immune_tolerance | 0.90675324 |
| 104 | MP0005647_abnormal_sex_gland | 0.90232792 |
| 105 | MP0002295_abnormal_pulmonary_circulatio | 0.89867539 |
| 106 | MP0003172_abnormal_lysosome_physiology | 0.89170898 |
| 107 | MP0005165_increased_susceptibility_to | 0.89132605 |
| 108 | MP0009780_abnormal_chondrocyte_physiolo | 0.88316237 |
| 109 | MP0001756_abnormal_urination | 0.88160789 |
| 110 | MP0003221_abnormal_cardiomyocyte_apopto | 0.87646395 |
| 111 | MP0001790_abnormal_immune_system | 0.86966226 |
| 112 | MP0005387_immune_system_phenotype | 0.86966226 |
| 113 | MP0004883_abnormal_blood_vessel | 0.85565019 |
| 114 | MP0002133_abnormal_respiratory_system | 0.85374597 |
| 115 | MP0005388_respiratory_system_phenotype | 0.85374597 |
| 116 | MP0008260_abnormal_autophagy | 0.85161614 |
| 117 | * MP0008469_abnormal_protein_level | 0.85142346 |
| 118 | MP0005332_abnormal_amino_acid | 0.84650239 |
| 119 | MP0003959_abnormal_lean_body | 0.83999316 |
| 120 | MP0000604_amyloidosis | 0.83310350 |
| 121 | * MP0009763_increased_sensitivity_to | 0.82946293 |
| 122 | MP0002269_muscular_atrophy | 0.82374724 |
| 123 | MP0005083_abnormal_biliary_tract | 0.78857126 |
| 124 | MP0005171_absent_coat_pigmentation | 0.78775592 |
| 125 | MP0005266_abnormal_metabolism | 0.77561003 |
| 126 | MP0005595_abnormal_vascular_smooth | 0.72155892 |
| 127 | MP0003868_abnormal_feces_composition | 0.71618333 |
| 128 | MP0000465_gastrointestinal_hemorrhage | 0.69185201 |
| 129 | MP0002009_preneoplasia | 0.68584092 |
| 130 | MP0002106_abnormal_muscle_physiology | 0.68466820 |
| 131 | MP0004145_abnormal_muscle_electrophysio | 0.67794321 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.35992595 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.35992595 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 4.35992595 |
| 4 | Oligomenorrhea (HP:0000876) | 4.07415101 |
| 5 | Acanthosis nigricans (HP:0000956) | 3.69521967 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.63504512 |
| 7 | Hypertriglyceridemia (HP:0002155) | 3.61822479 |
| 8 | Myoglobinuria (HP:0002913) | 3.59384246 |
| 9 | Frequent falls (HP:0002359) | 3.58951033 |
| 10 | Eczematoid dermatitis (HP:0000976) | 3.50321896 |
| 11 | Myocardial infarction (HP:0001658) | 3.48033967 |
| 12 | Hyperglycinuria (HP:0003108) | 3.42332612 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 3.39361468 |
| 14 | Nausea (HP:0002018) | 3.34255125 |
| 15 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.28317347 |
| 16 | Bone cyst (HP:0012062) | 3.27789726 |
| 17 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.25954459 |
| 18 | Complement deficiency (HP:0004431) | 3.20427731 |
| 19 | Increased cerebral lipofuscin (HP:0011813) | 3.18538432 |
| 20 | Increased connective tissue (HP:0009025) | 3.17863712 |
| 21 | Hypoglycemic coma (HP:0001325) | 3.12931756 |
| 22 | Muscle fiber splitting (HP:0003555) | 3.10644297 |
| 23 | Hematochezia (HP:0002573) | 3.10004725 |
| 24 | Vacuolated lymphocytes (HP:0001922) | 3.05055544 |
| 25 | Difficulty running (HP:0009046) | 3.04815176 |
| 26 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.99476421 |
| 27 | Recurrent abscess formation (HP:0002722) | 2.99293783 |
| 28 | Axonal loss (HP:0003447) | 2.97594958 |
| 29 | Hypoalphalipoproteinemia (HP:0003233) | 2.94812813 |
| 30 | Sudden death (HP:0001699) | 2.91717835 |
| 31 | Rhabdomyolysis (HP:0003201) | 2.87060237 |
| 32 | Lipoatrophy (HP:0100578) | 2.85730407 |
| 33 | Ventricular tachycardia (HP:0004756) | 2.83868012 |
| 34 | Polycythemia (HP:0001901) | 2.83706805 |
| 35 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.82908426 |
| 36 | Paralysis (HP:0003470) | 2.82610773 |
| 37 | Bundle branch block (HP:0011710) | 2.81031590 |
| 38 | Hypercholesterolemia (HP:0003124) | 2.79272789 |
| 39 | Ketoacidosis (HP:0001993) | 2.79147418 |
| 40 | Right ventricular cardiomyopathy (HP:0011663) | 2.70296356 |
| 41 | Abnormality of complement system (HP:0005339) | 2.69446477 |
| 42 | Abnormality of macrophages (HP:0004311) | 2.68452383 |
| 43 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.67306684 |
| 44 | Abnormality of glycine metabolism (HP:0010895) | 2.67306684 |
| 45 | Esophageal varix (HP:0002040) | 2.63693335 |
| 46 | Autoimmune thrombocytopenia (HP:0001973) | 2.61882509 |
| 47 | Recurrent bacterial skin infections (HP:0005406) | 2.61005579 |
| 48 | Amyloidosis (HP:0011034) | 2.59941323 |
| 49 | Tetraparesis (HP:0002273) | 2.59565422 |
| 50 | Asymmetric septal hypertrophy (HP:0001670) | 2.58520266 |
| 51 | Hyporeflexia of lower limbs (HP:0002600) | 2.57799873 |
| 52 | Hyperlipoproteinemia (HP:0010980) | 2.54269306 |
| 53 | Xanthomatosis (HP:0000991) | 2.54243732 |
| 54 | Neck muscle weakness (HP:0000467) | 2.53690585 |
| 55 | Hydroxyprolinuria (HP:0003080) | 2.49901039 |
| 56 | Abnormality of proline metabolism (HP:0010907) | 2.49901039 |
| 57 | Skin nodule (HP:0200036) | 2.48903228 |
| 58 | Hemorrhage of the eye (HP:0011885) | 2.48410582 |
| 59 | Facial diplegia (HP:0001349) | 2.46934787 |
| 60 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.46417865 |
| 61 | Exercise-induced muscle cramps (HP:0003710) | 2.45713882 |
| 62 | Epidermoid cyst (HP:0200040) | 2.45138559 |
| 63 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.44136184 |
| 64 | Ketosis (HP:0001946) | 2.43871912 |
| 65 | Colitis (HP:0002583) | 2.43819984 |
| 66 | EMG: myopathic abnormalities (HP:0003458) | 2.43767116 |
| 67 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.43671850 |
| 68 | Dicarboxylic aciduria (HP:0003215) | 2.43671850 |
| 69 | Spontaneous hematomas (HP:0007420) | 2.41002566 |
| 70 | Cerebral aneurysm (HP:0004944) | 2.38289838 |
| 71 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.36926713 |
| 72 | Type 1 muscle fiber predominance (HP:0003803) | 2.36127074 |
| 73 | Muscle fiber inclusion bodies (HP:0100299) | 2.35496169 |
| 74 | Interstitial pulmonary disease (HP:0006530) | 2.33880211 |
| 75 | Nemaline bodies (HP:0003798) | 2.33674307 |
| 76 | Exercise-induced myalgia (HP:0003738) | 2.33424927 |
| 77 | Hyperammonemia (HP:0001987) | 2.32014751 |
| 78 | Mucosal telangiectasiae (HP:0100579) | 2.31771722 |
| 79 | Loss of speech (HP:0002371) | 2.29547455 |
| 80 | Poikilocytosis (HP:0004447) | 2.29104177 |
| 81 | Ventricular fibrillation (HP:0001663) | 2.28100953 |
| 82 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.27489504 |
| 83 | Abnormality of the periventricular white matter (HP:0002518) | 2.27436916 |
| 84 | Nephritis (HP:0000123) | 2.25388930 |
| 85 | Cerebral hemorrhage (HP:0001342) | 2.25359492 |
| 86 | Palpitations (HP:0001962) | 2.23815818 |
| 87 | Hepatosplenomegaly (HP:0001433) | 2.23325483 |
| 88 | Distal lower limb muscle weakness (HP:0009053) | 2.22163461 |
| 89 | * Prolonged bleeding time (HP:0003010) | 2.21727315 |
| 90 | Atrial fibrillation (HP:0005110) | 2.20688212 |
| 91 | Dysostosis multiplex (HP:0000943) | 2.17331164 |
| 92 | Neoplasm of head and neck (HP:0012288) | 2.17330615 |
| 93 | Esophageal neoplasm (HP:0100751) | 2.17330615 |
| 94 | Pigmentary retinal degeneration (HP:0001146) | 2.16771894 |
| 95 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.16463891 |
| 96 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.16463891 |
| 97 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.16463891 |
| 98 | Purpura (HP:0000979) | 2.15657417 |
| 99 | Disinhibition (HP:0000734) | 2.15059932 |
| 100 | Generalized aminoaciduria (HP:0002909) | 2.13589704 |
| 101 | Vertebral compression fractures (HP:0002953) | 2.13479433 |
| 102 | Conjunctival hamartoma (HP:0100780) | 2.13306612 |
| 103 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.13134147 |
| 104 | Insulin resistance (HP:0000855) | 2.12327712 |
| 105 | Growth hormone excess (HP:0000845) | 2.11224278 |
| 106 | Abnormality of purine metabolism (HP:0004352) | 2.11161681 |
| 107 | Increased muscle lipid content (HP:0009058) | 2.10359671 |
| 108 | Abnormal atrioventricular conduction (HP:0005150) | 2.09904910 |
| 109 | Increased serum pyruvate (HP:0003542) | 2.08482568 |
| 110 | Heart block (HP:0012722) | 2.06797786 |
| 111 | Atrioventricular block (HP:0001678) | 2.06002660 |
| 112 | Broad metatarsal (HP:0001783) | 2.04875496 |
| 113 | Gingivitis (HP:0000230) | 1.99548308 |
| 114 | Primary atrial arrhythmia (HP:0001692) | 1.99290047 |
| 115 | Glomerulonephritis (HP:0000099) | 1.98880116 |
| 116 | Mutism (HP:0002300) | 1.98377485 |
| 117 | Osteolytic defects of the hand bones (HP:0009699) | 1.98313166 |
| 118 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.98313166 |
| 119 | Dilated cardiomyopathy (HP:0001644) | 1.95773462 |
| 120 | Toxemia of pregnancy (HP:0100603) | 1.94357800 |
| 121 | Ventricular arrhythmia (HP:0004308) | 1.93839230 |
| 122 | Abnormality of glycolysis (HP:0004366) | 1.93709190 |
| 123 | Abnormality of the lumbar spine (HP:0100712) | 1.93286138 |
| 124 | Fatigue (HP:0012378) | 1.93283642 |
| 125 | Abnormal hemoglobin (HP:0011902) | 1.92304040 |
| 126 | Supraventricular arrhythmia (HP:0005115) | 1.91836730 |
| 127 | Mucopolysacchariduria (HP:0008155) | 1.88690940 |
| 128 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.88690940 |
| 129 | Subcapsular cataract (HP:0000523) | 1.87115008 |
| 130 | Calf muscle hypertrophy (HP:0008981) | 1.87089856 |
| 131 | Multiple enchondromatosis (HP:0005701) | 1.86593359 |
| 132 | Joint hemorrhage (HP:0005261) | 1.86495080 |
| 133 | Abnormality of the nasal mucosa (HP:0000433) | 1.85971374 |
| 134 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.85689642 |
| 135 | Foot dorsiflexor weakness (HP:0009027) | 1.85673704 |
| 136 | Increased variability in muscle fiber diameter (HP:0003557) | 1.84852818 |
| 137 | Diaphragmatic weakness (HP:0009113) | 1.84737187 |
| 138 | Rimmed vacuoles (HP:0003805) | 1.84691588 |
| 139 | Pancreatitis (HP:0001733) | 1.84259445 |
| 140 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.82943872 |
| 141 | Epistaxis (HP:0000421) | 1.82272891 |
| 142 | Keratoconjunctivitis sicca (HP:0001097) | 1.82081694 |
| 143 | Abnormality of the foot musculature (HP:0001436) | 1.79734921 |
| 144 | Inflammation of the large intestine (HP:0002037) | 1.79597064 |
| 145 | Cerebral inclusion bodies (HP:0100314) | 1.78776721 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 4.10803825 |
| 2 | TRIB3 | 3.96390586 |
| 3 | CAMK1D | 3.38077587 |
| 4 | RIPK1 | 2.62115224 |
| 5 | TTN | 2.60231221 |
| 6 | BCKDK | 2.51569838 |
| 7 | TGFBR2 | 2.50509375 |
| 8 | ERN1 | 2.32672397 |
| 9 | PRPF4B | 2.24221763 |
| 10 | PDK3 | 2.23800833 |
| 11 | PDK4 | 2.23800833 |
| 12 | SIK1 | 2.15407367 |
| 13 | CAMK1G | 2.15166565 |
| 14 | NEK9 | 1.94018377 |
| 15 | PDK2 | 1.90814829 |
| 16 | MAP3K13 | 1.86944792 |
| 17 | PKN2 | 1.85074446 |
| 18 | KDR | 1.84795105 |
| 19 | LMTK2 | 1.83212792 |
| 20 | DDR2 | 1.69891166 |
| 21 | FGFR3 | 1.66388914 |
| 22 | MAP3K6 | 1.66023368 |
| 23 | TBK1 | 1.65315649 |
| 24 | MST1R | 1.61443040 |
| 25 | CCNB1 | 1.57259089 |
| 26 | OBSCN | 1.55078640 |
| 27 | JAK1 | 1.53715419 |
| 28 | TYK2 | 1.49582907 |
| 29 | FES | 1.48079824 |
| 30 | MAPK4 | 1.42341186 |
| 31 | MYLK | 1.40985429 |
| 32 | RIPK4 | 1.39571666 |
| 33 | IRAK3 | 1.33861239 |
| 34 | MAP2K3 | 1.32925576 |
| 35 | MAP3K14 | 1.32355955 |
| 36 | CAMKK2 | 1.31004571 |
| 37 | FGFR4 | 1.29725941 |
| 38 | CAMK1 | 1.27318264 |
| 39 | PRKAA2 | 1.26317425 |
| 40 | PBK | 1.24099485 |
| 41 | PKN1 | 1.21527255 |
| 42 | KIT | 1.20429951 |
| 43 | ERBB3 | 1.19991931 |
| 44 | EEF2K | 1.19662238 |
| 45 | MAPKAPK3 | 1.19383275 |
| 46 | EPHB1 | 1.16949663 |
| 47 | DMPK | 1.14181888 |
| 48 | JAK2 | 1.13904876 |
| 49 | CSK | 1.11406338 |
| 50 | MAP3K3 | 1.08682256 |
| 51 | PIK3CG | 1.04055421 |
| 52 | JAK3 | 1.03902848 |
| 53 | PHKG2 | 1.03827230 |
| 54 | PHKG1 | 1.03827230 |
| 55 | NME2 | 0.99712868 |
| 56 | GRK7 | 0.97843323 |
| 57 | PDGFRA | 0.95715228 |
| 58 | PDPK1 | 0.94608437 |
| 59 | CDK6 | 0.94094544 |
| 60 | BTK | 0.93491836 |
| 61 | ABL2 | 0.93422805 |
| 62 | INSRR | 0.93115214 |
| 63 | MAPK7 | 0.89982843 |
| 64 | SCYL2 | 0.87344732 |
| 65 | TRPM7 | 0.87338914 |
| 66 | BLK | 0.85712650 |
| 67 | LRRK2 | 0.85680776 |
| 68 | PIK3CA | 0.84415335 |
| 69 | ARAF | 0.84148193 |
| 70 | BRAF | 0.82822532 |
| 71 | MOS | 0.81554137 |
| 72 | PTK6 | 0.81493073 |
| 73 | PTK2B | 0.78714964 |
| 74 | PRKD1 | 0.78330872 |
| 75 | STK24 | 0.77943851 |
| 76 | CSF1R | 0.77182491 |
| 77 | IRAK4 | 0.75651146 |
| 78 | MAP4K1 | 0.75053841 |
| 79 | PDK1 | 0.73091447 |
| 80 | PRKCH | 0.72782484 |
| 81 | BMPR2 | 0.72386371 |
| 82 | PDGFRB | 0.71157042 |
| 83 | ZAP70 | 0.70394673 |
| 84 | EPHB2 | 0.69898586 |
| 85 | MAPKAPK5 | 0.68542499 |
| 86 | MAP3K1 | 0.68008757 |
| 87 | BMX | 0.66248470 |
| 88 | FGFR2 | 0.65402790 |
| 89 | GSK3A | 0.63626342 |
| 90 | IKBKE | 0.62901181 |
| 91 | ILK | 0.61800355 |
| 92 | TEC | 0.61428907 |
| 93 | KSR2 | 0.60655026 |
| 94 | CDK9 | 0.60203354 |
| 95 | LYN | 0.59893655 |
| 96 | MARK3 | 0.59257578 |
| 97 | FLT3 | 0.58834243 |
| 98 | IKBKB | 0.58581955 |
| 99 | GRK5 | 0.58009444 |
| 100 | IGF1R | 0.57944504 |
| 101 | PRKAA1 | 0.57858336 |
| 102 | MET | 0.57690871 |
| 103 | TESK1 | 0.56188773 |
| 104 | ABL1 | 0.55261247 |
| 105 | MAPK12 | 0.53499427 |
| 106 | MAP2K1 | 0.53187472 |
| 107 | FER | 0.51873557 |
| 108 | HCK | 0.50989509 |
| 109 | FRK | 0.50181378 |
| 110 | PINK1 | 0.50017153 |
| 111 | NLK | 0.49254715 |
| 112 | PRKACB | 0.49072735 |
| 113 | PIM2 | 0.48705443 |
| 114 | PRKG1 | 0.48589898 |
| 115 | BRSK2 | 0.47876448 |
| 116 | EPHA3 | 0.47867751 |
| 117 | FGR | 0.47607955 |
| 118 | TGFBR1 | 0.47102058 |
| 119 | MAP3K5 | 0.45794718 |
| 120 | PRKACG | 0.45335493 |
| 121 | EGFR | 0.44714316 |
| 122 | ADRBK1 | 0.44659539 |
| 123 | DAPK2 | 0.43930057 |
| 124 | TNK2 | 0.43598004 |
| 125 | LATS2 | 0.43009123 |
| 126 | MAPK3 | 0.42095172 |
| 127 | RET | 0.42005984 |
| 128 | DAPK3 | 0.41333281 |
| 129 | PRKG2 | 0.41008699 |
| 130 | TAOK2 | 0.40701848 |
| 131 | MAP2K4 | 0.38920210 |
| 132 | CDC42BPA | 0.38278762 |
| 133 | STK10 | 0.36604660 |
| 134 | ITK | 0.36319422 |
| 135 | SGK3 | 0.35637139 |
| 136 | STK4 | 0.35113974 |
| 137 | LATS1 | 0.33656196 |
| 138 | STK3 | 0.31701594 |
| 139 | SYK | 0.31548178 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.53979668 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.45416064 |
| 3 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 3.23834701 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.13951597 |
| 5 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.99189820 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.94585025 |
| 7 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.84465652 |
| 8 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.51311577 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.48560145 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.43737103 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.37079743 |
| 12 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.77088348 |
| 13 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.61638070 |
| 14 | Carbon metabolism_Homo sapiens_hsa01200 | 1.60113058 |
| 15 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.58211236 |
| 16 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.54920350 |
| 17 | Lysosome_Homo sapiens_hsa04142 | 1.52904497 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.47509625 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.46740173 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.42465545 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.27753665 |
| 22 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.23775915 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.22843266 |
| 24 | Leishmaniasis_Homo sapiens_hsa05140 | 1.18249786 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.14665377 |
| 26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.13679104 |
| 27 | * Insulin resistance_Homo sapiens_hsa04931 | 1.13511259 |
| 28 | Asthma_Homo sapiens_hsa05310 | 1.09308458 |
| 29 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.08067370 |
| 30 | Pertussis_Homo sapiens_hsa05133 | 1.06025643 |
| 31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.05475002 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.98496597 |
| 33 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.98141075 |
| 34 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.97624359 |
| 35 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.97234158 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 0.94862292 |
| 37 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.94760579 |
| 38 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.94615067 |
| 39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.93138053 |
| 40 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.91527602 |
| 41 | Legionellosis_Homo sapiens_hsa05134 | 0.91297657 |
| 42 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.89764161 |
| 43 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.89311253 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87539261 |
| 45 | Allograft rejection_Homo sapiens_hsa05330 | 0.87253405 |
| 46 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.83811811 |
| 47 | * Phagosome_Homo sapiens_hsa04145 | 0.82988589 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.81403710 |
| 49 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.81062492 |
| 50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81032884 |
| 51 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.78221408 |
| 52 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.77458271 |
| 53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76964019 |
| 54 | * Malaria_Homo sapiens_hsa05144 | 0.76469622 |
| 55 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.76408744 |
| 56 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.75045794 |
| 57 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.75006197 |
| 58 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.74105807 |
| 59 | Focal adhesion_Homo sapiens_hsa04510 | 0.73865116 |
| 60 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.73267432 |
| 61 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.73256182 |
| 62 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.73191703 |
| 63 | Amoebiasis_Homo sapiens_hsa05146 | 0.71469259 |
| 64 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70742643 |
| 65 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.68848022 |
| 66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.68361992 |
| 67 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.66914158 |
| 68 | Other glycan degradation_Homo sapiens_hsa00511 | 0.64396540 |
| 69 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.64390673 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 0.64287942 |
| 71 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.61179839 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60285363 |
| 73 | * Fat digestion and absorption_Homo sapiens_hsa04975 | 0.58501987 |
| 74 | Salmonella infection_Homo sapiens_hsa05132 | 0.58426461 |
| 75 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58073153 |
| 76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57539105 |
| 77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.57241087 |
| 78 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57190491 |
| 79 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56339111 |
| 80 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.54335046 |
| 81 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.52487065 |
| 82 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.50254812 |
| 83 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.49795068 |
| 84 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49660052 |
| 85 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.49313427 |
| 86 | * ECM-receptor interaction_Homo sapiens_hsa04512 | 0.49029083 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47614784 |
| 88 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.47276312 |
| 89 | Platelet activation_Homo sapiens_hsa04611 | 0.47035733 |
| 90 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.45604311 |
| 91 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.45428312 |
| 92 | Renin secretion_Homo sapiens_hsa04924 | 0.45350148 |
| 93 | Adherens junction_Homo sapiens_hsa04520 | 0.45270915 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45048263 |
| 95 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.44054582 |
| 96 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.43701075 |
| 97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43650649 |
| 98 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.43535512 |
| 99 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.43421590 |
| 100 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.43097709 |
| 101 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.42995033 |
| 102 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.41253060 |
| 103 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.40907107 |
| 104 | Influenza A_Homo sapiens_hsa05164 | 0.40159853 |
| 105 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40024301 |
| 106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.39244909 |
| 107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.38672316 |
| 108 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.38461390 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.37766205 |
| 110 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37187589 |
| 111 | Apoptosis_Homo sapiens_hsa04210 | 0.36826499 |
| 112 | Measles_Homo sapiens_hsa05162 | 0.36782676 |
| 113 | Lysine degradation_Homo sapiens_hsa00310 | 0.36779818 |
| 114 | Hepatitis C_Homo sapiens_hsa05160 | 0.36419274 |
| 115 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.35112032 |
| 116 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.33570009 |
| 117 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.33447453 |
| 118 | Bile secretion_Homo sapiens_hsa04976 | 0.32718272 |
| 119 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.32473658 |
| 120 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.32347572 |
| 121 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.32005621 |
| 122 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.31379359 |
| 123 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.30447648 |
| 124 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.30240292 |
| 125 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.29379133 |
| 126 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28992094 |
| 127 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28763094 |
| 128 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.28118500 |
| 129 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.26573706 |
| 130 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.26160046 |
| 131 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.25743730 |

